12个候选单核苷酸多态性位点与中国儿童急性淋巴细胞白血病易感性和预后的关系

doi:10.3969/j.issn.2095-9400.2021.07.002

摘要
图/表
参考文献(31)
相关文章 (15)

全文: PDF (1425 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：探讨12 个候选单核苷酸多态性（SNP）位点和中国儿童急性淋巴细胞白血病（ALL）易感性及预后的关系。方法：复习文献选取12 个候选SNP位点，采用多重PCR后靶向捕获二代测序技术检测各SNP的基因型。采用χ2检验及logistic回归分析对556 例ALL患儿和191 例健康志愿者进行病例-对照研究验证SNP位点与中国儿童ALL易感性的关系。采用Kaplan-Meier生存分析及Cox回归分析365 例ALL患儿SNP位点与ALL预后的关系。结果：Logistic回归分析显示SNP位点基因型与ALL风险增加显著相关：ARID5B 基因的rs10821936 风险等位基因C（OR =1.687，95%CI =1.318～2.135，P ＜0.001］和rs10994982 风险等位基因A（OR =1.594，95%CI =1.259～2.018，P ＜0.001），IKZF1 基因的rs11978267 风险等位基因G（OR =2.133，95%CI =1.495～3.043，P ＜0.001）和rs4132601风险等位基因G（OR =2.108，95%CI =1.466～3.031，P ＜0.001）以及ZNF230 基因的rs7554607 风险等位基因C（OR =1.481，95%CI =1.161～1.890，P =0.002）。多因素Cox回归分析显示无事件生存率的不良预后因素：SIAT7C 基因的rs10873876 位点TC基因型（HR =2.111，95%CI =1.260～3.539，P =0.005）以及LOC102723724 基因的rs11155133 位点GG基因型（HR =4.787，95%CI =1.652～13.870，P =0.004），同时它们也是复发率的不良预后因素（前者HR =2.082，95%CI =1.242～3.492，P =0.005，后者HR =4.067，95%CI =1.380～11.988，P =0.011）。结论：ARID5B 基因的rs10821936和rs10994982、ZNF230基因的rs7554607以及IKZF1 基因的rs11978267 和rs4132601为我国儿童ALL潜在易感性位点。SIAT7C 基因的rs10873876以及LOC102723724 基因的rs11155133多态性位点可作为ALL患儿的预后因素。

	服务
	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：急性淋巴细胞白血病, 易感性, 预后, 单核苷酸多态性

Abstract：Objective: To investigate the relationship of 12 candidate single nucleotide polymorphisms(SNP) loci with the susceptibility and prognosis of Chinese children with acute lymphoblastic leukemia (ALL).Methods: Review the literature and select 12 candidate SNP loci, and then detect the genotype of each SNP by multiplex PCR targeted capture next-generation sequencing technology. A case-control study on 556 children with ALL and 191 healthy volunteers was conducted using chi-square test and logistic regression analysis to verify the relationship between SNP loci and the susceptibility of Chinese children with ALL. Kaplan-Meier survival analysis and Cox regression were used to analyze the relationship between SNP loci and the prognosis of ALL in 365 ALL cases. Results: Logistic regression analysis showed that the genotype of the SNP locus was significantly correlated with the increased risk of ALL: the rs10821936 risk allele C (OR=1.687, 95%CI=1.318-2.135, P<0.001) and rs10994982 risk allele A (OR=1.594, 95%CI=1.259-2.018, P<0.001) of the ARID5B gene;rs11978267 risk allele G (OR=2.133, 95%CI=1.495-3.043, P<0.001) and rs4132601 risk allele G (OR=2.108,95%CI=1.466-3.031, P<0.001) of the IKZF1 gene and the rs7554607 risk allele C (OR=1.481, 95%CI=1.161-1.890, P=0.002) of the ZNF230 gene. Multivariate Cox regression analysis showed that the following were an poor prognostic factor of event-free survival rate: TC genotype at rs10873876 locus of SIAT7C gene (HR=2.111,95%CI=1.260-3.539, P=0.005) and GG genotype at rs11155133 locus of LOC102723724 gene (HR=4.787,95%CI=1.652-13.870, P=0.004). At the same time, they were also poor prognostic factors of recurrence rate (the former HR=2.082, 95%CI=1.242-3.492, P=0.005, the latter HR=4.067, 95%CI=1.380-11.988, P=0.011).Conclusion: The rs10821936 and rs10994982 of ARID5B gene, rs7554607 of ZNF230 gene, rs11978267 and rs4132601 of IKZF1 gene are the potential susceptibility loci of ALL in Chinese children. Polymorphism loci of rs10873876 of SIAT7C and rs11155133 of LOC102723724 can be prognostic factors for childhood ALL.

Key words： acute lymphoblastic leukemia susceptibility prognosis single nucleotide polymorphism

收稿日期: 2020-11-11

基金资助:国家转化医学中心（上海）开放课题资助项目[NRCTM（SH）2019-04]；国家自然科学基金资助项目（81270623）。

通讯作者: 沈树红，主任医师 E-mail: shenshuhong@scmc.com.cn。

作者简介: 王桢，硕士生，Email：WZ662754@163.com。

链接本文:

https://xb.wmu.edu.cn/CN/10.3969/j.issn.2095-9400.2021.07.002 或 https://xb.wmu.edu.cn/CN/Y2021/V51/I7/524

[1] HUNGER S P, MULLIGHAN C G. Acute lymphoblastic leukemia in children[J]. N Engl J Med, 2015, 373(16): 1541-1552.
[2] PUI C H, EVANS W E. Treatment of acute lymphoblastic leukemia[J]. N Engl J Med, 2006, 354(2): 166-178.
[3] LINABERY A M, ROSS J A. Trends in childhood cancer incidence in the U.S. (1992-2004)[J]. Cancer, 2008, 112(2):416-432.
[4] VROOMAN L M, SILVERMAN L B. Treatment of childhood acute lymphoblastic leukemia: prognostic factors and clinical advances[J]. Curr Hematol Malig Rep, 2016,11(5): 385-394.
[5] SHEN S,CAI J, CHEN J, et al. Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in China[J]. Hematol Oncol, 2018, 36(4): 679-688.
[6] BELSON M, KINGSLEY B, HOLMES A. Risk factors for acute leukemia in children: a review[J]. Environ Health Perspect, 2007, 115(1): 138-145.
[7] PAPAEMMANUIL E, HOSKING F J, VIJAYAKRISHNAN J,et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia [J]. Nat Genet, 2009, 41(9): 1006-1010.
[8] TREVIÑO L R,YANG W, FRENCH D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia[J]. Nat Genet, 2009, 41(9): 1001-1005.
[9] WANG Y, CHEN J, LI J, et al. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population[J]. Gene, 2013, 524(2): 203-207.
[10] TAO R, LIU Y J, LIU L F, et al. Genetic polymorphisms of ARID5B rs7089424 and rs10994982 are associated with Blineage ALL susceptibility in Chinese pediatric population[J]. J Chin Med Assoc, 2019, 82(7): 562-567.
[11] 莫一啸, 王桢, 王盼, 等. 12个单核苷酸多态性位点与儿童急性淋巴细胞白血病易感性的关系[J]. 温州医科大学学报, 2021, 51(1): 1-7.
[12] ROCHA J C, CHENG C, LIU W, et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia[J].Blood, 2005, 105(12): 4752-4758.
[13] KODIDELA S, PRADHAN S C, DUBASHI B, et al.Influence of dihydrofolate reductase gene polymorphisms rs408626 (-317A>G) and rs442767(-680C>A) on the outcome of methotrexate-based maintenance therapy in South Indian patients with acute lymphoblastic leukemia[J].Eur J Clin Pharmacol, 2015, 71(11): 1349-1358.
[14] ANSARI M, SAUTY G, LABUDA M, et al. Polymorphisms in multidrug resistance-associated protein gene 4 is associated with outcome in childhood acute lymphoblastic leukemia[J]. Blood, 2009, 114(7): 1383-1386.
[15] GREGERS J, GRéEN H, CHRISTENSEN I J, et al.Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia[J].Pharmacogenomics J, 2015, 15(4): 372-379.
[16] LI H, DURBIN R. Fast and accurate short read alignment with Burrows-Wheeler transform[J]. Bioinformatics, 2009,25(14): 1754-1760.
[17] LI H, HANDSAKER B, WYSOKER A, et al. The Sequence Alignment/Map format and SAMtools[J]. Bioinformatics,2009, 25(16): 2078-2079.
[18] WANG K, LI M, HAKONARSON H. ANNOVAR:functional annotation of genetic variants from highthroughput sequencing data[J]. Nucleic Acids Res, 2010,38(16): e164.
[19] MOSAAD Y M, EL-ZINY M A, DARWISH A, et al. IKZF1 rs4132601 and rs11978267 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome[J]. J Pediatr Hematol Oncol, 2020, 42(7): 420-428.
[20] YANG J J, CHENG C, YANG W, et al. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia[J]. JAMA, 2009, 301(4): 393-403.
[21] XU H, CHENG C, DEVIDAS M, et al. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia[J]. J Clin Oncol, 2012, 30(7): 751-757.
[22] MOSAAD Y M, KHASHABA M, DARWISH A, et al.ARID5B rs10821936 and rs10994982 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome[J]. Pediatr Hematol Oncol, 2019,36(6): 365-375.
[23] MULLIGHAN C G, MILLER C B, RADTKE I, et al. BCRABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros[J]. Nature, 2008, 453(7191): 110-114.
[24] BIELSKA M, BOROWIEC M, JESIONEK-KUPNICKA D,et al. Polymorphism in IKZF1 gene affects clinical outcome in diffuse large B-cell lymphoma[J]. Int J Hematol, 2017,106(6): 794-800.
[25] ZHAO Y, LI Y, MA H, et al. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma[J]. Mol Cell Proteomics,2014, 13(2): 520-536.
[26] SCHULTZ M J, SWINDALL A F, WRIGHT J W, et al.ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells[J]. J Ovarian Res, 2013, 6(1): 25.
[27] LIU Q, MA H, SUN X, et al. The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia[J]. J Exp Clin Cancer Res, 2019, 38(1): 199.
[28] LAMMENS T, DURINCK K, WALLAERT A, et al. Long non-coding RNAs in leukemia: biology and clinical impact[J]. Curr Opin Hematol, 2017, 24(4): 353-358.
[29] ALVAREZ-DOMINGUEZ J R, LODISH H F. Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis[J]. Blood, 2017, 130(18):1965-1975.
[30] DE LA ROSA R, VILLEGAS-RUÍZ V, CABALLEROPALACIOS M C, et al. Expression of ZNF695 transcript variants in childhood B-cell acute lymphoblastic leukemia[J]. Genes (Basel), 2019, 10(9): 716.
[31] BÁRCENAS-LÓPEZ D A, NÚÑEZ-ENRíQUEZ J C,HIDALGO-MIRANDA A, et al. Transcriptome analysis identifies LINC00152 as a biomarker of early relapse and mortality in acute lymphoblastic leukemia[J]. Genes (Basel),2020, 11(3): 302.